Evidence map›Paper›PMID 10675358›Full record

ArticleThe Journal of clinical investigation2000

A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism.

A Tabarin, J C Achermann, D Recan, V Bex, X Bertagna, S Christin-Maitre, M Ito, J L Jameson, P Bouchard

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical investigation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 194 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Case Report: A Novel Truncating Variant ofFrontiers in endocrinology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Identification and Functional Analysis of SixJournal of the Endocrine Society · 2019
    Article
  13. Article
  14. Genetic disorders of nuclear receptors.The Journal of clinical investigation · 2017
    Review
  15. Article
  16. Article
  17. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.Best practice & research. Clinical endocrinology & metabolism · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

A TabarinDépartement d'Endocrinologie, Diabétologie du CHU de Bordeaux, USN Haut Levêque, 33604 Pessac, France. antoine.tabarin@chu-aquitaine.fr
J C Achermann
D Recan
V Bex
X Bertagna
S Christin-Maitre
M Ito
J L Jameson
P Bouchard
Northwestern University · USHôpital Cardiologique du Haut-Lévêque · FRSorbonne Université · FRHôpital Cochin · FRInstitut de Biochimie et Biophysique Moléculaire et Cellulaire · FR

Funding

WOMEN'S INTERAGENCY HIV STUDY (WIHS) INTENSIVE PHARMACOKINETICS STUDYM01RR000048 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DUNAIF, ANDREA · 1985 to 2007
$21.1M
TREATMENT OF INFERTILITY DUE TO OVULATORY DYSFUNCTIONU54HD029164 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI SLUSS, PATRICK · 1991 to 2002
$3.9M
NCRR NIH HHS M01 RR000048NCRR NIH HHS MO1 RR00048NICHD NIH HHS U54-HD-29164
6 · The paper itself

Abstract

Mutations in the DAX1 gene cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HHG). In affected boys, primary adrenal insufficiency occurs soon after birth or during early childhood; HHG is recognized at the expected time of puberty. In this report, we describe the novel phenotype of a man who presented with apparently isolated adrenal insufficiency at 28 years of age. Examination revealed partial pubertal development and undiagnosed incomplete HHG. Gonadotropin therapy did not improve his marked oligospermia, suggesting a concomitant primary testicular abnormality. Genomic analysis revealed a novel missense mutation, I439S, in DAX1. The mutant DAX-1 protein was studied for its ability to function as a transcriptional repressor of target genes. Consistent with the patient's mild clinical phenotype, the I439S mutation conferred intermediate levels of repressor activity of DAX-1 when compared with mutations associated with classic AHC. This unique case extends the clinical spectrum of AHC to include delayed-onset primary adrenal insufficiency in adulthood and milder forms of HHG. Furthermore, in accordance with findings in Ahch (Dax1) knockout mice, the clinical features in this patient suggest that DAX-1 function is required for spermatogenesis in humans, independent of its known effects on gonadotropin production.

Indexed as

MutationRepressor ProteinsAdrenal GlandsAdultAge of OnsetAnimalsDAX-1 Orphan Nuclear ReceptorDNA-Binding ProteinsHumansHypogonadismMaleMiceMice, KnockoutReceptors, Retinoic AcidTranscription FactorsDAX-1 Orphan Nuclear ReceptorDNA-Binding ProteinsNR0B1 protein, humanNr0b1 protein, mouseReceptors, Retinoic AcidRepressor ProteinsTranscription Factors

Identifiers

PMID10675358
PMCPMC377437
OpenAlexW2168933737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.